期刊文献+

脂蛋白脂酶基因与代谢综合征关系的研究进展 被引量:1

Research Progress of Lipoprotein Lipase Gene and Metabolic Syndrome
原文传递
导出
摘要 脂蛋白脂酶是脂质代谢的关键酶之一,是血浆中清除甘油三酯的限速酶,主要催化乳糜微粒和极低密度脂蛋白核心中的甘油三酯水解,使得机体能够利用由食物摄取和肝脏合成的脂肪,同时释放出脂肪酸和单酰甘油。脂蛋白脂酶基因突变可以影响脂蛋白脂酶的活性,从而导致脂代谢紊乱,与肥胖、胰岛素抵抗、2型糖尿病和高血压的发病风险相关。本文综述了脂蛋白脂酶的结构、功能、基因结构及其多态性与血脂和代谢综合征关系的研究进展。 Lipoprotein lipase(LPL) is the key enzyme in the lipid metabolism and is the rate-limiting enzyme of cleaning triglyceride in plasma,it catalyses the hydrolysis of the triglyceride component of chylomicrons and very low density lipoproteins,it can halp body utilizes fatty from food and liver and provids fatty acids and monoacylglycerol for tissue utilization LPL gene mutation may affect the activity of LPL,and results in lipid metabolism disorder. It is associated with obesity,insulin resistance,type 2 diabetes and hypertension. Here we review the structure,function LPL gene structure and polymorphism along with its association with the lipid and metabolic sydrome.
出处 《现代生物医学进展》 CAS 2009年第21期4181-4183,4139,共4页 Progress in Modern Biomedicine
基金 新疆生产建设兵团国际科技合作项目(2009YD33)
关键词 脂蛋白脂酶 基因多态性 代谢综合征 lipoprotein lipase gene polymorphism mctabolic syndrome
  • 相关文献

参考文献17

  • 1Goldberg I J,Kandel J J,Blum C B,et al.Association of plasma lipoproteins with postheparin lipase activities [J]. J Clin Invest, 1986,78(6): 1523-1528.
  • 2Goldberg I J, Merkel M. Lipoprotein lipase: physiology, biochemistry, and molecular biology[J]. Frontiers in Bioscience, 2001,6:d388-405.
  • 3张蓉,樊云,刘宇,刘秉文.2型糖尿病与脂蛋白脂酶基因HindⅢ酶切位点的多态性[J].基础医学与临床,2004,24(2):141-144. 被引量:4
  • 4Tu X, Tu JW, Wen XY, et al. A study of lipoprotein lipase gene intron 8 polymorphisms in Chinese Han race essential hypertension patients[J], international Journal of Cardiology, 2005, 99:263-267.
  • 5张洪,刘付贞.脂蛋白脂酶基因HindⅢ多态性与肥胖者胰岛素抵抗的关系[J].广东医学,2007,28(11):1801-1804. 被引量:5
  • 6李凤翱,朱梅,张鹏,邱明才.脂蛋白脂酶Hind Ⅲ酶切多态性与2型糖尿病患者血脂及冠心病的关系[J].中国组织工程研究与临床康复,2007,11(34):6781-6784. 被引量:2
  • 7Javorsk YM, Gasperikova D, Ukropet J, et al. Lipoprotein lipase Hindlll polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease [J]. Wien Klin Wochenschr, 2007,119(15-16): 476-482.
  • 8Chen W, Sathanur R.S, Abdalla E, et al. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa Heart Study [J]. Atherosclerosis, 2001,159:367-373.
  • 9黄爱群,胡永华,徐波,詹思延,吕筠,秦颖,曹卫华,李立明.双生子中脂蛋白脂酶基因S447X突变与血脂、血压的关联和连锁分析[J].北京大学学报(医学版),2005,37(6):585-590. 被引量:7
  • 10Liu A, Lee L, Zhan S, et al. The S447X polymorphism of the lipoprotein lipase gene is associated with lipoprotein lipid and blood pressure levels in Chinese patients with essential hypertension [J]. J Hypertens, 2004,22(8): 1503-1509.

二级参考文献66

  • 1龙石银,张蓉,田英,徐燕华,傅明德.肥胖者高密度脂蛋白亚类组成与脂蛋白酯酶基因多态性的关系[J].中国动脉硬化杂志,2006,14(2):170-174. 被引量:6
  • 2葛光岩,宋林萱,崔晓栋,丁金芝,宋医风,曲晶,赵亮.脂蛋白脂酶基因HindⅢ多态性与胰岛素抵抗关系的研究[J].中国医师杂志,2006,8(10):1412-1413. 被引量:3
  • 3[美]费朗西斯科乔阿耶拉 约翰亚基杰.[M].长沙:湖南科学技术出版社,1987..
  • 4Ahn YI, Kamboh MI, Hamman RF, et al. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res, 1993, 34:421-428.
  • 5Georges JL, Regis-Bailly A, Salah D, et al. Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels. Genet Epidemiol, 1996, 13:179-192.
  • 6Ehrenborg E, Clee SM, Pimstone SN, et al. Ethnic variation and in vivo effect of the -93t→g promoter variant in the lipoprotein lipase gene. Arterioscler Thromb Vasc Biol, 1997,17:2672-2678.
  • 7Hallman DM,Srinivasan SR, Elkasabany A, et al. The Ser(447)-Stop polymorphism of lipoprotein lipase is associated with variation in longitudinal serum high-density lipoprotein-cholesterol profiles: the Bogalusa heart study. Metabolism, 2001, 50:894-904.
  • 8Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids, and lipoproteins and risk of ischemic heart disease: A meta-analysis. Circulation,1999,99:2901-2907.
  • 9Groenemeijer BE, Hallaman MD, Reymer PW, et al. Genetic variant showing a positive interaction with β-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation,1997,95:2628-2635.
  • 10Mattu RK, Needham EWA, MorGan R, et al. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb,1994,14:1090-1097.

共引文献25

同被引文献16

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部